Hyperhidrosis Treatment

(Excessive Sweating)

Botox is a safe and effective solution for managing severe hyperhidrosis, or excessive sweating, in specific areas of the body. It functions by temporarily inhibiting the nerve signals that trigger overactivity in the sweat glands.

How Toxins Work For Hyperhidrosis

Botulinum toxin type A, the active ingredient in Botox, is injected directly into the targeted area to specifically address overactive sweat glands while preserving other functions. By blocking nerve signals, Botox significantly reduces the activity of the sweat glands, leading to a noticeable decrease in sweat production. The effects provide temporary but long-lasting relief, typically lasting between 3 to 12 months, though individual results may vary, requiring repeat treatments to sustain the benefits.

Areas Treatable With Toxins

Underarms (Axillary): This is the most common and extensively researched application of Botox for treating hyperhidrosis. Clinical studies have demonstrated an 82% to 87% reduction in sweating.
Palmar: Botox is an effective treatment for excessive sweating in the palms, although it is known to be more painful and may lead to temporary, localized muscle weakness.
Feet (Plantar): This area can be treated; however, some patients may experience increased pain during the injection, and the treatment might be less effective and shorter in duration compared to other body parts.
Face and scalp (craniofacial): Although less researched, Botox injections can effectively reduce excessive sweating in these areas.

Benefits Of Toxins For Hyperhidrosis

minimal pain when injected in the armpits
generally safe
can be an effective treatment, with one study finding a 90 percent decrease in sweat production 2 weeks after the procedure

How Long Does It Last?

Like other toxin treatments, hyperhidrosis toxin treatment lasts approximately 3-4 months

Who Is A Good Candidate?

Individuals with severe primary axillary hyperhidrosis (excessive underarm sweating) that is not adequately managed with topical agents.
Patients who are 18 years of age or older.
Those who have failed to respond to other treatment options, like topical antiperspirants containing aluminum chloride.
Individuals who do not have certain medical conditions that may interfere with neuromuscular function, such as myasthenia gravis or Lambert-Eaton syndrome.
Those without active infections at the injection site or systemic infections.
Non-pregnant and non-breastfeeding women.